As a predictive target of MAPK8, the drug HESPERADIN was shown to reduce arthritis scores, arthritis index, and inhibit serum levels of TNF-6, IL-17A, and CRP in CIA rats, and to exhibit analgesic, anti-inflammatory, and antipyretic potential in experimental animals50. The gene discussed is IL17A; the disease is arthritic joint disease.